Strain et al., 2022 - Google Patents
Effect of diet on pathogen performance in the microbiomeStrain et al., 2022
View HTML- Document ID
- 13765350263829965695
- Author
- Strain R
- Stanton C
- Ross R
- Publication year
- Publication venue
- Microbiome Research Reports
External Links
Snippet
Intricate interactions among commensal bacteria, dietary substrates and immune responses are central to defining microbiome community composition, which plays a key role in preventing enteric pathogen infection, a dynamic phenomenon referred to as colonisation …
- 230000001717 pathogenic 0 title abstract description 107
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhao et al. | Intestinal microbiota and chronic constipation | |
Kapourchali et al. | Early‐life gut microbiome—the importance of maternal and infant factors in its establishment | |
JP7266636B2 (en) | Therapeutic microflora for the treatment and/or prevention of food allergies | |
Patil et al. | Interactions between host and gut microbiota in domestic pigs: a review | |
Walsh et al. | Beneficial modulation of the gut microbiota | |
Celiberto et al. | Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome | |
Capurso | Thirty years of Lactobacillus rhamnosus GG: a review | |
Singh et al. | Influence of diet on the gut microbiome and implications for human health | |
Wang et al. | Protective effects of different Bacteroides vulgatus strains against lipopolysaccharide-induced acute intestinal injury, and their underlying functional genes | |
Davis | The gut microbiome and its role in obesity | |
Lau et al. | Probiotic administration can prevent necrotizing enterocolitis in preterm infants: a meta-analysis | |
Yang et al. | The impact of dietary fiber and probiotics in infectious diseases | |
EP3313422B1 (en) | Compositions comprising a bacterial strain of blautia hydrogenotrophica for use in the treatment or prevention of diarrhea or constipation | |
Cresci et al. | Gut microbiome: what we do and don't know | |
Nagao-Kitamoto et al. | Pathogenic role of the gut microbiota in gastrointestinal diseases | |
Szajewska et al. | Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy | |
Fedorak et al. | Probiotics and prebiotics in gastrointestinal disorders | |
Saulnier et al. | Microbiology of the human intestinal tract and approaches for its dietary modulation | |
JP5905032B2 (en) | Synbiotic composition for recovery and reconstitution of intestinal microbiota | |
Underwood et al. | A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids | |
JP2022020856A (en) | Use of purified 2'-fucosyllactose, 3-fucosyllactose, and lactodifucotetraose as prebiotics | |
Ganguli et al. | Probiotics in the prevention of necrotizing enterocolitis | |
Hajela et al. | Gut microbiome, gut function, and probiotics: Implications for health | |
Cho et al. | The interface of Vibrio cholerae and the gut microbiome | |
Strain et al. | Effect of diet on pathogen performance in the microbiome |